Notes to SEFA
Title: Subrecipients
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule)
includes the federal grant activity of Bloodworks Northwest (the Organization or Bloodworks) under
programs of the federal government for the year ended June 30, 2024. The information in this schedule is
presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200,
Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards
(Uniform Guidance). Because the Schedule presents only a selected portion of the operations of
Bloodworks, it is not intended to and does not present the financial position, changes in net assets or
cash flows of Bloodworks.
Expenditures reported on the Schedule are reported on the accrual basis of
accounting. Such expenditures are recognized following the cost principles contained in the Uniform
Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of
business to amounts reported as expenditures in prior years. Pass-through entity identifying numbers are
presented where available.
De Minimis Rate Used: N
Rate Explanation: Bloodworks did not elect to use the 10 percent de minimis cost rate.
Of the federal expenditures presented in the Schedule, under Assistance Listing No. 93.839, Blood Diseases and Resources Research, Bloodworks provided federal awards to three subrecipients. See the Notes to the SEFA for chart/table.
Title: Subrecipients
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule)
includes the federal grant activity of Bloodworks Northwest (the Organization or Bloodworks) under
programs of the federal government for the year ended June 30, 2024. The information in this schedule is
presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200,
Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards
(Uniform Guidance). Because the Schedule presents only a selected portion of the operations of
Bloodworks, it is not intended to and does not present the financial position, changes in net assets or
cash flows of Bloodworks.
Expenditures reported on the Schedule are reported on the accrual basis of
accounting. Such expenditures are recognized following the cost principles contained in the Uniform
Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of
business to amounts reported as expenditures in prior years. Pass-through entity identifying numbers are
presented where available.
De Minimis Rate Used: N
Rate Explanation: Bloodworks did not elect to use the 10 percent de minimis cost rate.
Of the federal expenditures presented in the Schedule, under Assistance Listing No. 12.420, Military Medical Research and Development, Bloodworks provided federal awards to one subrecipient. See the Notes to the SEFA for chart/table.